C.R. Bard Upgraded by Goldman Sachs Group Inc. to Neutral (BCR)
C.R. Bard (NYSE:BCR) was upgraded by analysts at Goldman Sachs Group Inc. from a “sell” rating to a “neutral” rating in a research report issued to clients and investors on Wednesday, AnalystRatingsNetwork reports.
Other equities research analysts have also recently issued reports about the stock. Analysts at Citigroup Inc. reiterated a “neutral” rating on shares of C.R. Bard in a research note to investors on Monday, October 14th. They now have a $124.00 price target on the stock, up previously from $123.00. Separately, analysts at Needham & Company initiated coverage on shares of C.R. Bard in a research note to investors on Wednesday, September 4th. They set a “hold” rating on the stock. Finally, analysts at Zacks reiterated a “neutral” rating on shares of C.R. Bard in a research note to investors on Tuesday, September 3rd. They now have a $121.00 price target on the stock. One investment analyst has rated the stock with a sell rating, thirteen have given a hold rating and six have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $117.31.
In other C.R. Bard news, COO John H. Weiland sold 84,525 shares of C.R. Bard stock in a transaction dated Monday, October 21st. The shares were sold at an average price of $125.62, for a total transaction of $10,618,030.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Shares of C.R. Bard (NYSE:BCR) opened at 126.96 on Wednesday. C.R. Bard has a 52 week low of $93.79 and a 52 week high of $119.99. The stock’s 50-day moving average is $115.6 and its 200-day moving average is $107.2. The company has a market cap of $10.049 billion and a price-to-earnings ratio of 57.37.
C.R. Bard (NYSE:BCR) last posted its quarterly earnings results on Tuesday, October 22nd. The company reported $1.50 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.40 by $0.10. The company had revenue of $758.00 million for the quarter, compared to the consensus estimate of $739.12 million. During the same quarter in the prior year, the company posted $1.64 earnings per share. The company’s quarterly revenue was up 4.9% on a year-over-year basis. On average, analysts predict that C.R. Bard will post $5.94 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Friday, November 1st. Shareholders of record on Monday, October 21st will be given a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a yield of 0.66%. The ex-dividend date of this dividend is Thursday, October 17th.
C. R. Bard, Inc (NYSE:BCR) is engaged in the design, manufacture, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.